A Three‐Pronged Epigenetic Approach to the Treatment of Hepatocellular Carcinoma

Abstract excerpt

See article on page 1412 Hepatocellular carcinoma (HCC) is among the fastest‐growing causes of cancer‐related death in the United States due to a lack of early detection strategies, increased incidence driven in part by metabolic syndrome, and limited treatment options. Multikinase inhibitors (sorafenib/regorafenib) and immune checkpoint inhibitors (nivolumab) are the three Food and Drug Administration...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy in Disease and Therapy
• Share to Epigenetics and DNA Methylation
• Share to RNA modifications and cancer